🇺🇸 FDA
Patent

US 7321063

Sulfonamide inhibitors of aspartyl protease

granted A61KA61K38/00

Quick answer

US patent 7321063 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00